Brian Ritchie
Analyst, LifeSci Advisors
Replay available
Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call
Soleno Therapeutics, Inc. (NASDAQ: SLNO) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Anish Bhatnagar
Chairman and Chief Executive Officer, Celeno Therapeutics
Meredith Manning
Chief Commercial Officer, Celeno Therapeutics
Jim McInnes
Chief Financial Officer, Celeno Therapeutics
Yasmin Rahimi
Analyst, Piper Sandler
Rye Forseth
Analyst, Guggenheim
Kristen Kluska
Analyst, Kantor
Tyler Van Buren
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Soleno Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.297 -- 00:00:06.302 Greetings and welcome to the Solano Second Quarter 2025 Earnings Conference 00:00:06.302 -- 00:00:10.827 Call. At this time, all participants are in a listen-only mode. 00:00:10.827 -- 00:00:15.132 If anyone should require operator assistance, please press star zero on your telephone 00:00:15.132 -- 00:00:20.458 keypad. A question and answer session will follow the formal presentation. 00:00:20.458 -- 00:00:24.642 You may press star one at any time to be placed into the question queue, and we ask that 00:00:24.642 -- 00:00:28.786 you please ask one question and one follow-up, then return to the queue. 00:00:28.786 -- 00:00:31.829 As a reminder, this conference is being recorded. 00:00:31.829 -- 00:00:36.153 It's now my pleasure to turn the call over to Brian Ritchie of LifeSci Advisors. 00:00:36.153 -- 00:00:38.874 Please go ahead, Brian. 00:00:39.637 -- 00:00:45.563 Thank you. Good afternoon, everyone, and thank you for joining us to discuss Celano Therapeutics' 00:00:45.563 -- 00:00:50.408 second quarter 2025 financial and operating results. 00:00:50.408 -- 00:00:55.012 Please note, we'll be making certain forward-looking statements today. 00:00:55.012 -- 00:01:00.036 We refer you to Celano's SEC filings for a discussion of the risks that 00:01:00.036 -- 00:01:05.383 may cause actual results to differ from the forward-looking statements. 00:01:05.383 -- 00:01:10.430 On the call with me today for Celeno are Anish Bhatnagar, Celeno's Chairman 00:01:10.430 -- 00:01:15.537 and Chief Executive Officer, Meredith Manning, Celeno's Chief Commercial Officer, 00:01:15.537 -- 00:01:19.042 and Jim McInnes, Celeno's Chief Financial Officer. 00:01:19.042 -- 00:01:23.025 With that, I will now turn the call over to Anish. 00:01:24.189 -- 00:01:2...